Global Type 1 Diabetes Market Analysis and Forecast Report 2030
Diabetes is a metabolic disease in which pancreases is no longer able to secrete adequate insulin inside the pancreas. Diabetes is characterized by high blood glucose or high blood sugar level. Diabetes is primarily of 3 types-type 1, type 2, and diabetes. Type 1 diabetes is a medical condition in which pancreas secrete less or no insulin. It occurs when immune system destroys or attacks the insulin making cells in the pancreas. These cells are known as beta cells.
Global Type 1 Diabetes Market is expected to project a notable CAGR of XX.X% in 2030.
Global Type 1 Diabetes Market to surpass USD XXXX million by 2030 from USD XXXX million in 2019 at a CAGR of XX.X% in the coming years, i.e., 2020-30. Factors such as sedentary lifestyles, increasing prevalence of chronic diseases ,unhealthy diet routine coupled with growing obesity rates are bolstering the market growth.
Global Type 1 Diabetes Market: Segments
Rapid-Acting Insulin segment to grow with the highest CAGR during 2020-30
Global Type 1 Diabetes market is segmented by Insulin Analog into Rapid-Acting Insulin Analogs, Long-Acting Insulin Analogs and Premix Insulin Analogs. Rapid-Acting Insulin, segment held the largest market share of XX.X% in the year 2019 as they act very quickly to reduce the rise in blood sugar level which follows eating. Rapid-Acting Insulin is usually taken just before or with the meal. It can either be delivered or injected through an insulin pump.
Technological advances in insulin delivery
Advent of several new class of diabetics drugs and advancements in insulin delivery are the key factors propelling the market growth. The growing demand for minimally invasive and non-invasive insulin delivery is expected to spur the market growth in the near future. The introduction of early insulin pumps and blood glucose meters, the development of new technologies and integration of consumer electronics and cloud-based data systems is likely to provide a strong impetus to the market growth. Other factors that are driving the market growth includes approval of insulin smart pens that records the timing and amount of insulin doses, with information exchanged with mobile apps to monitor patterns and make recommendations for dosing, developments in CGM and insulin pump technology, and the incorporation of CGM and insulin pumps into hybrid closed-loop systems that can change the delivery of insulin on the basis of live glucose measurements.
High cost of treatment
Treatment therapies and diagnosis cost associated with diabetes is considerably high which can hinder the growth of type 1 diabetes market globally. Besides, unfavorable reimbursement policies is anticipated to inhibit the growth of market in the coming years.
Global Type 1 Diabetes Market: Key Players
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Eli Lilly and Company
Johnson & Johnson Ltd
Merck & C0.
Other Prominent Players
Global Type 1 Diabetes Market: Regions
Global Type 1 Diabetes Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific and Middle East and Africa. Global Type 1 Diabetes Market in North America held the largest market share of XX.X% in the year 2019. North America will continue to dominate the global Type 1 Diabetes market owing to rising healthcare expenditure, growing geriatric population and changing lifestyle of people. In addition, several diabetes control and awareness initiatives organized by government in the region is anticipated to further bolster the market growth. High adoption of technological advancements in the region is projected to support the market growth.
Related Reports: Global Greenhouse Irrigation System Market Analysis and Forecast Report 2030